Literature DB >> 19763146

The role of means and goals in technology acceptance. A differentiated landscape of public perceptions of pharming.

Rafael Pardo1, Margret Engelhard, Kristin Hagen, Rikke Bagger Jørgensen, Eckard Rehbinder, Angelika Schnieke, Mariana Szmulewicz, Felix Thiele.   

Abstract

Mesh：

Year:  2009        PMID： 19763146      PMCID： PMC2759743          DOI： 10.1038/embor.2009.208

Source DB:  PubMed          Journal:  EMBO Rep        ISSN： 1469-221X            Impact factor:   8.807


× No keyword cloud information.
  15 in total

1.  The influence of trust and perceptions of risks and benefits on the acceptance of gene technology.

Authors:  M Siegrist
Journal:  Risk Anal       Date:  2000-04       Impact factor: 4.000

Review 2.  Transgenic plants as factories for biopharmaceuticals.

Authors:  G Giddings; G Allison; D Brooks; A Carter
Journal:  Nat Biotechnol       Date:  2000-11       Impact factor: 54.908

3.  Public concerns in the United Kingdom about general and specific applications of genetic engineering: risk, benefit, and ethics.

Authors:  Lynn J Frewer; Chaya Howard; Richard Shepherd
Journal:  Sci Technol Human Values       Date:  1997

4.  The "trust gap" hypothesis: predicting support for biotechnology across national cultures as a function of trust in actors.

Authors:  Susanna Hornig Priest; Heinz Bonfadelli; Maria Rusanen
Journal:  Risk Anal       Date:  2003-08       Impact factor: 4.000

5.  Attitudes toward biotechnology in the European Union.

Authors:  Rafael Pardo; Cees Midden; Jon D Miller
Journal:  J Biotechnol       Date:  2002-09-11       Impact factor: 3.307

Review 6.  After Dolly--ethical limits to the use of biotechnology on farm animals.

Authors:  Jesper Lassen; Mickey Gjerris; Peter Sandøe
Journal:  Theriogenology       Date:  2005-10-25       Impact factor: 2.740

7.  Are Europeans really antagonistic to biotech?

Authors:  Rafael Pardo; Felix Calvo
Journal:  Nat Biotechnol       Date:  2006-04       Impact factor: 54.908

8.  Attitudes to biotechnology: estimating the opinions of a better-informed public.

Authors:  Patrick Sturgis; Helen Cooper; Chris Fife-Schaw
Journal:  New Genet Soc       Date:  2005-04

9.  Join the dots.

Authors: 
Journal:  Nat Biotechnol       Date:  2008-08       Impact factor: 54.908

10.  Europe ambivalent on biotechnology. Biotechnology and the European Public Concerted Action group.

Authors: 
Journal:  Nature       Date:  1997-06-26       Impact factor: 49.962
View more
  3 in total

1.  A new era for plant biotechnology. A combination of pharmaceutical applications, technologies and safety measures could lead to new applications for genetically modified plants.

Authors:  Philip Hunter
Journal:  EMBO Rep       Date:  2011-06       Impact factor: 8.807

2.  Is biotechnology (more) acceptable when it enables a reduction in phytosanitary treatments? A European comparison of the acceptability of transgenesis and cisgenesis.

Authors:  Damien Rousselière; Samira Rousselière
Journal:  PLoS One       Date:  2017-09-06       Impact factor: 3.240

Review 3.  Design and construction of "synthetic species".

Authors:  Eduardo Moreno
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.